IntelGenx Technologies Corp. (CVE:IGX – Get Free Report)’s share price shot up 1.8% during mid-day trading on Friday . The stock traded as high as C$0.60 and last traded at C$0.58. 11,848 shares were traded during mid-day trading, a decline of 79% from the average session volume of 56,279 shares. The stock had previously closed at C$0.57.
IntelGenx Technologies Price Performance
The company has a fifty day simple moving average of C$0.58 and a 200-day simple moving average of C$0.58. The company has a market cap of C$87.32 million and a P/E ratio of -7.44. The company has a debt-to-equity ratio of 164.62, a current ratio of 2.77 and a quick ratio of 2.69.
About IntelGenx Technologies
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.
Featured Stories
- Five stocks we like better than IntelGenx Technologies
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Is Spotify Stock Poised to Soar? Options Traders Think So
- 5 discounted opportunities for dividend growth investors
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Using the MarketBeat Dividend Yield Calculator
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
